Boxer Capital as of Dec. 31, 2023
Portfolio Holdings for Boxer Capital
Boxer Capital holds 52 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 9.4 | $188M | 3.2M | 58.75 | |
| Cytokinetics Com New (CYTK) | 8.7 | $175M | 2.1M | 83.49 | |
| Springworks Therapeutics (SWTX) | 6.2 | $125M | 3.4M | 36.50 | |
| Revolution Medicines (RVMD) | 6.1 | $123M | 4.3M | 28.68 | |
| Apellis Pharmaceuticals (APLS) | 5.1 | $103M | 1.7M | 59.86 | |
| BeiGene Sponsored Adr (BGNE) | 4.5 | $90M | 500k | 180.36 | |
| Tyra Biosciences (TYRA) | 4.5 | $89M | 6.4M | 13.85 | |
| ImmunoGen | 4.4 | $88M | 3.0M | 29.65 | |
| Nuvalent Inc-a (NUVL) | 4.1 | $82M | 1.1M | 73.59 | |
| Tango Therapeutics (TNGX) | 4.0 | $81M | 8.2M | 9.90 | |
| Karuna Therapeutics Ord | 3.9 | $79M | 250k | 316.51 | |
| Ideaya Biosciences (IDYA) | 3.9 | $78M | 2.2M | 35.58 | |
| Sarepta Therapeutics (SRPT) | 3.1 | $63M | 650k | 96.43 | |
| Argenx SE Sponsored Adr (ARGX) | 3.0 | $61M | 160k | 380.43 | |
| Merus N V (MRUS) | 2.6 | $52M | 1.9M | 27.50 | |
| Rocket Pharmaceuticals (RCKT) | 2.2 | $44M | 1.5M | 29.97 | |
| Immunovant (IMVT) | 2.1 | $42M | 1.0M | 42.13 | |
| Akero Therapeutics (AKRO) | 2.0 | $39M | 1.7M | 23.35 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.8 | $36M | 600k | 60.17 | |
| Axsome Therapeutics (AXSM) | 1.6 | $32M | 400k | 79.59 | |
| Arcus Biosciences Incorporated (RCUS) | 1.5 | $31M | 1.6M | 19.10 | |
| Anaptysbio Inc Common (ANAB) | 1.4 | $28M | 1.3M | 21.42 | |
| Xenon Pharmaceuticals (XENE) | 1.4 | $28M | 600k | 46.06 | |
| Arvinas Ord (ARVN) | 1.2 | $25M | 609k | 41.16 | |
| Prothena Corp SHS (PRTA) | 1.2 | $24M | 665k | 36.34 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $20M | 1.7M | 12.25 | |
| Relay Therapeutics (RLAY) | 1.0 | $20M | 1.8M | 11.01 | |
| Iteos Therapeutics (ITOS) | 1.0 | $20M | 1.8M | 10.95 | |
| Day One Biopharmaceuticals I (DAWN) | 0.9 | $17M | 1.2M | 14.60 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.8 | $16M | 400k | 40.76 | |
| Oric Pharmaceuticals (ORIC) | 0.8 | $16M | 1.7M | 9.20 | |
| Iovance Biotherapeutics (IOVA) | 0.6 | $11M | 1.4M | 8.13 | |
| Prelude Therapeutics (PRLD) | 0.5 | $11M | 2.6M | 4.27 | |
| Avidity Biosciences Ord (RNA) | 0.5 | $10M | 1.1M | 9.05 | |
| Nkarta (NKTX) | 0.5 | $9.5M | 1.4M | 6.60 | |
| Enliven Therapeutics (ELVN) | 0.4 | $8.9M | 646k | 13.84 | |
| Third Harmonic Bio (THRD) | 0.4 | $8.2M | 750k | 10.97 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.3 | $6.8M | 450k | 15.15 | |
| Geron Corporation (GERN) | 0.3 | $6.3M | 3.0M | 2.11 | |
| Spyre Therapeutics Com New (SYRE) | 0.3 | $5.4M | 250k | 21.52 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.1 | $2.2M | 238k | 9.13 | |
| Fate Therapeutics (FATE) | 0.1 | $1.9M | 500k | 3.74 | |
| Kodiak Sciences (KOD) | 0.1 | $1.8M | 600k | 3.04 | |
| Bioatla (BCAB) | 0.1 | $1.7M | 686k | 2.46 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $1.4M | 506k | 2.81 | |
| Rain Therapeutics | 0.1 | $1.4M | 1.2M | 1.20 | |
| Milestone Pharmaceuticals (MIST) | 0.0 | $516k | 309k | 1.67 | |
| DBV Technologies S A Sponsored Adr (DBVT) | 0.0 | $476k | 500k | 0.95 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $392k | 209k | 1.88 | |
| Atreca Cl A Com (BCEL) | 0.0 | $291k | 2.2M | 0.13 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $16k | 267k | 0.06 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.3k | 67k | 0.02 |
